2021 Safety and Availability Communications

This webpage was developed to provide the public with important information about the safety and availability of biological products.

March 2021

• FDA Requires a Warning about Guillain-Barré Syndrome (GBS) be Included in the Prescribing Information for Shingrix
  March 24, 2021

February 2021

• COVID-19 Vaccine Safety Surveillance
  February 9, 2021

January 2021

• Updated Information for Blood Establishments Regarding the COVID-19 Pandemic and Blood Donation
  January 19, 2021

• Updated Information for Human Cell, Tissue, or Cellular or Tissue-based Product (HCT/P) Establishments Regarding the COVID-19 Pandemic
  January 4, 2021